ABBOTT LABORATORIES (ABT) Balance sheet
Top 20 of 35 line items reported by ABT · 250+ in the full API →
ABBOTT LABORATORIES (ABT) · Balance Sheet
Consolidated Balance Sheets
Annual · In millions USD · Latest as of Dec 31, 2025
| As of | |||||
|---|---|---|---|---|---|
FY2025 Dec 31, 2025 | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 | Trend | |
| Total Assets | $86,713 | $81,414 | $73,214 | $74,438 | |
| Total Current Assets | $25,996 | $23,656 | $22,670 | $25,224 | |
| Property, Plant & Equipment, net | 11,816 | 10,658 | 10,154 | 9,162 | |
| Operating leased assets | 1,126 | 1,075 | 1,122 | 1,116 | |
| Equity and other investments | 918 | 886 | 799 | 766 | |
| Goodwill | 24,035 | 23,108 | 23,679 | 22,799 | |
| Intangible assets | 5,526 | 6,647 | 8,815 | 10,454 | |
| Total Liabilities | $34,583 | $33,750 | $34,611 | $37,752 | |
| Total Current Liabilities | $16,496 | $14,157 | $13,841 | $15,489 | |
| Long-term debt | 9,896 | 12,625 | 13,599 | 14,522 | |
| Operating lease liabilities | 931 | 896 | 949 | 943 | |
| Pension & retiree benefits | 2,125 | 1,880 | 1,964 | 1,784 | |
| Other long-term liabilities | 2,538 | 3,443 | 3,466 | 3,804 | |
| Total Shareholders' Equity | $52,130 | $47,664 | $38,603 | $36,686 | |
| Common Stock | 25,527 | 25,153 | 24,869 | 24,709 | |
| Treasury stock, at cost | (17,177) | (16,844) | (15,981) | (15,229) | |
| Current Ratio | 1.58 | 1.67 | 1.64 | 1.63 | |
| Quick Ratio | 1.02 | 1.05 | 1.00 | 1.06 | |
| Debt-to-Equity Ratio | 0.25 | 0.30 | 0.38 | 0.46 | |
| Working Capital | 9,500 | 9,499 | 8,829 | 9,735 | |
15 more line items available via the API
Cash & Short-Term InvestmentsCash & EquivalentsShort-Term InvestmentsAccounts ReceivableInventoryCurrent DebtCurrent Portion of Long-Term DebtAccrued LiabilitiesIncome Taxes PayableUnearned RevenueRetained EarningsAccumulated other comprehensive incomeAllowance for doubtful accountsDTA valuation allowanceUnrecognized tax benefits